Journal Editors and Co-authors

I am surprised that New England Journal of Medicine subscribers have heard no more from Benish, Cryar, Lind-Ackerson, Benish, Popp, Hourani, Rutt, Junger, Goldstein, Fibs, Barbas, Rist, Sugar, Cryar and Mellinger. You may remember them as the authors of a famous letter to NEJM in which they announced a tie for the honor of writing the paper in that journal with the greatest number of authors in 1985 (NEJM, vol. 313, 1985, p. 331). The accolade went jointly to Lauristen, Rune, Bytzer, Kelbaek, Je

Written byBernard Dixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It was a splendid, magnanimous compliment from a modest 15-author team to two teams of 16 authors apiece. What happened in 1986 we have yet to learn. As a regular reader of NEJM, my impression is that things have improved. Certainly, 1987 began quietly with a six-piece band as the largest group of authors in the first issue of the year. In the scientific literature at large, however, the problem of multiple authorship remains formidable. With the arguable exception of particle physics, in which international collaborations can genuinely orchestrate the labors of dozens of researchers, it is hard to believe that many alleged joint authors have made sufficient contributions to justify that reward. Does the technician who takes the electron micrographs using standard techniques really merit equal recognition alongside the scientist who interprets the pictures and designs the experiments in the first place?

The obvious fraternity to sort out this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies